The Ohio State University

Ohio Union

1739 N. High St.

Columbus, OH

USA

OHIO STATE’S DIABETES RESEARCH CENTER PRESENTS

The Second

Global Diabetes Summit New Horizons in Diabetes: Genetics to Personalized Health Care

November 14 -17, 2012

2

The Second

Global Diabetes Summit New Horizons in Diabetes: Genetics to Personalized Health Care

During this three-day symposium, diabetes experts will present

the latest outcomes in diabetes research and formulate an

interdisciplinary road map for prevention, detection, management

and treatment of diabetes.

For more information contact:

Lindsay CowgillProgram ManagerCenter for Continuing Medical EducationP.O. Box 182721660 Ackerman Road, Building 5, Second floorColumbus, Ohio 43202Tel: 614-293-3576Fax: 614-293-4180E-mail: lindsay.cowgill@osumc.edu

Kwame Osei, MD, FACE, FACP Chair, Ohio State’s Global Diabetes Summit Ralph W. Kurtz, Chair of Endocrinology and Exercise PhysiologyDirector, OSU Diabetes Research CenterProfessor of MedicineThe Ohio State University Wexner Medical Center491 Campbell Hall | 1581 Dodd Drive | Columbus, Ohio 43210Tel: 614-685-3333Fax: 614-366-3329E-mail: kwame.osei@osumc.edu

3

The U.S. National Diabetes Prevention Program: Implementing What We Have Learned from Research Ann Albright, PhD, RDCenters for Disease Control and Prevention

Lessons from Islet Cell Transplantation Registry Rodolfo Alejandro, MD University of Miami

Diabetes in Special Populations – Blacks and West IndiansAlbert G.B. Amoah MB.ChB, PhD, FRCP, FWACP, FGCP, FESC, FGA University of Ghana

Ethnic Differences in Metabolic Syndrome in Minority Women Maria Rosario Araneta, PhD University of Southern California, San Diego

Pathogenesis of Type 2 Diabetes in Youth: Importance of Ethnicity Silva Arslanian, MD University of Pittsburgh

New Technologies and Diabetes Richard Bergenstal, MD International Diabetes Center at Park Nicollet

Pathophysiology of Diabetes in Pregnancy: Lessons from TRIPOD and PIPOD Thomas Buchanan, MD University of Southern California, Los Angeles

Understanding the Effect of Cost-Sharing, Access to and Utilization of, Diabetes Self-Management and Training Sandra Burke, PhD, ANP, BC-ADM, CDE, FAADE University of Illinois at Urbana-Champaign

Metabolic Syndrome and Diabetes in West Indies Michael Boyne, MBChB, FRCPC University of West Indies at Mona

Diabetes in Special Populations – Diabetes in LatinosU.S. Diabetes Prevention Study – 5 Year Legacy Study in U.S.Enrique Caballero, MD Harvard University

Metabolic Syndrome and Obese Youth Sonia Caprio, MD Yale University

Historical and Future Perspectives of New Guidelines in GDM: Would it Change the Maternal Fetal Outcome?Donald R. Coustan, MD Brown University

Diabetes in Latinos: Impact of Immigration and Culture Jaime Davidson, MD, FACE, FACP University of Texas at Austin

The Era of TZDs, DPP-IV Inhibitors and GLP-1 Analogs Ralph DeFronzo, MD University of Texas at San Antonio

Confirmed speakers include: (in alphabetical order)

4

Oral Agents and Pregnancy Outcome Celeste Durnwald, MD University of Pennsylvania

Future Oral Anti-Diabetic Medications on the Horizon: Promises and Pitfalls Vivian Fonseca, MD, FRCP Tulane University

Diabetes and Pregnancy Steven G. Gabbe, MD The Ohio State University

Type 1 Diabetes – New Immunological Approaches to Preserve Beta Cell Function Kevan Herold, MD Yale University

Non-Classic Forms of Autoimmune and Non-Autoimmune Diabetes Irl Hirsch, MD University of Washington

Legacy Effects of Cardiovascular Outcome Studies: Metabolic Memory – UKPDS to ACCORD Rury Holman, MD, FRCP Oxford University

Diabetes in Postmenopausal Women – The Women’s Health Initiative Barbara V. Howard, PhD Georgetown University

Look Ahead: Comprehensive Understanding of Management of Type 2 Diabetes in Multi-Ethnic Populations Samuel Dagogo-Jack, MD, FACE University of Tennessee, Memphis

Ethnicity and Personalized Health Care: Diabetes in WomenRebecca Jackson, MD The Ohio State University

Prevention of Diabetes in India (IDDP 1 and 2) Shashank R. Joshi, MD, FACE, FRCP Research Society for the Study of Diabetes in India and Indian Academy of Diabetes

Selection of Insulin Therapy in Pregnancy on Fetal Outcomes: Fiction or Reality? Lois Jovanovic, MD, MACE Sansum Diabetes Research Institute

Obesity, Youth and Diabetes (DiaObesity)Francine Kaufman, MD Children’s Hospital Los Angeles

Closing the Loop Aaron Kowalski, PhD Juvenile Diabetes Research Foundation

Diabetes in Pregnancy: Controversies Surrounding GDM Mark B. Landon, MD The Ohio State University

The Future Horizon of Global Diabetes and Obesity in Developing Countries Naomi Levitt, MB, ChB, MD University of Cape Town

Global Pandemic of Obesity and Diabetes in Adults – Epidemiological Solutions and ChallengesDiabetes Prevention Trials: Perspectives of IDFJean Claude Mbanya, MD, PhD, FRCP University of Yaoundee

Pathophysiology of Type 2 Diabetes in Asian Indians V. Mohan, MB, ChB, FRCP Madras Diabetes Research Foundation

5

Metabolic Syndrome and Diabetes in South African Blacks Ayesha Motala, MB, ChB University of KwaZulu-Natal

Personalized Care and Diabetes: The Role of Pharmacogenetics Ewan Pearson, MD University of Dundee

Lessons from International Pancreas Transplantation Registry Amer Rajab, MD, PhD The Ohio State University

Diabetes and YouthDavid Repaske, MD, PhD Nationwide Children’s Hospital

Genomics and Diabetes: Implications of Personalized Health Griffin Rodgers, MD, MBA, MACP National Institutes of Health Advances in Health Disparities - Genetics Research Charles Rotimi, PhD National Institutes of Health

Biochemistry of Wound Healing: Role of Antioxidants Chandan Sen, PhD, FACSM, FACN The Ohio State University

Can Type 1 Diabetes Be Prevented? Jay Skyler, MD, MACP University of Miami

Personalized Care and Pharmacogenetics of Diabetes Soren Snitker, MD, PhD University of Maryland

Glucose Sensors William Tamborlane, MD Yale University Finnish Diabetes Prevention Study – 20 Year Legacy Study in Finland Jaakko Tuomilehto MD, PhD University of Helsinki

Ethnic Differences – Diabetes in Subpopulations of Latinos Guillermo Umpierrez, MD Emory University

Lifestyle and Exercise in Diabetes Prevention in ChinaDa Qing Diabetes Prevention Study – 23 Year Legacy Study in ChinaJainping Weng, MD Sun Yat-sen University

Initial Combination Therapy for Type 2 Diabetes: Is it Ready for Prime Care? Bernard Zinman, MDCM, FRCP, FACP University of Toronto

4 | 5

For more information about the Summit, visit Ohio State’s Diabetes Research Center web site at diabetesresearch.osu.edu.

Special Invited Guest:Frances Collins, MD, PhD National Institutes of Health

6

To register online,Visit ccme.osu.edu and click on “View All Conferences”, then select the

“Second Global Diabetes Summit”. You must be logged into an OSU CCME account to register.

If you do not have an account, click on the red “Sign Up” button.

If you encounter any issues with the registration system, contact the CME office at (614) 293-3576.

Cancellation PolicyRequests for cancellation must be submitted in writing and postmarked on or before 5 p.m. EST, October 12, 2012. (Requests postmarked by this date will receive a full refund). No refunds can be made for cancellation requests postmarked after this date. The Ohio State University reserves the right to cancel this program at any time and will assume no financial obligation to the registrants in the event of cancellation. If the course is cancelled, registration fees will be refunded in full.

Accommodations and HotelsRoom blocks at several area hotels have been made for GDS participants. Please visit the conference website for hotel and accommodation information. Visit ccme.osu.edu, click on “View All Conferences” and then select “Second Global Diabetes Summit”.

Accreditation StatementThe Ohio State University Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation StatementThe Ohio State University Center for Continuing Medical Education designates this live activity for a maximum of 18 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other CertificationsSummit planners are seeking continuing medical education certifications for several other specialty areas. Approval of additional certification (other than AMA PRA Category 1 Credit™ for physicians) is pending application approval and cannot be guaranteed.

Course RegistrationRegistrant Information

Suffix* Mr. Mrs. Ms. Miss. Dr.

___________________________________________________________________________________________________________Name*

Degree(s)* MD DO PhD RN CNP Other _______________________________________

___________________________________________________________________________________________________________Medical Specialty

___________________________________________________________________________________________________________Address*

___________________________________________________________________________________________________________

City* State/Country* ZIP*

___________________________________________________________________________________________________________Daytime Telephone Fax

___________________________________________________________________________________________________________Email*Important - A valid email address is required at time of registration to create or confirm the existence of an OSU CCME account. Failure to provide a valid email address may cause a delay in the processing of program registration and the awarding of CME credits earned.

Global Diabetes Summit Concurrent Session Selection (Please select ONE from each section) If you do not make selections, you will be assigned based on availability.

Concurrent Workshops 1 - Thursday, November 15 - 4 -5 p.m.n Workshop 1A - Tissue Therapies and Biologics in Diabetes

n Workshop 1B - Cellular Therapies of Diabetes

n Workshop 1C - Understanding the Effect of Cost-Sharing Access to and Utilization of Diabetes Self-Management and Training

Concurrent Symposia C - Friday, November 16 - 9:45 a.m.-noonn Symposium C1 - Immunology of Type 1 Diabetes

n Symposium C2 - New Technologies and Diabetes

Concurrent Workshops 2 - Friday, November 16 - 2-3:30 p.m.n Workshop 2A - Diabetes in Special Populations: Black and West Indians

n Workshop 2B - Diabetes in Special Populations: Continental East Asians

n Workshop 2C - Diabetes in Special Populations: Diabetes in Latinos

n Workshop 2D - Ethnicity and Personalized Health Care: Diabetes in Women

Concurrent Plenary - Saturday, November 17 - 8-11:45 a.m.n Plenary Session V - Diabetes and Pregnancy

n Plenary Session VI - Lessons from Legacy Studies in Diabetes Prevention Trials

Course Fees Early Bird Program Fees Regular Program Fees

(Through July 31, 2012) (After July 31, 2012)

Physicians n $450 n $500Non-Physicians n $300 n $350 Make Checks Payable to: The Ohio State University

n Check enclosed, in US Dollars

Credit Card Information

n VISA n Mastercard n Discover n AMEX Credit Card Number ____________________________________________Expiration Date _________________________________________________

Return To:Center for Continuing Medical Education

The Ohio State University Wexner Medical Center

600 Ackerman Rd - E2058

PO Box 182721

Columbus, OH 43202 USA

ccme.osu.edu

Cen

ter

for

Con

tinui

ng M

edic

al E

duca

tion

The

Ohi

o S

tate

Uni

vers

ity W

exne

r M

edic

al C

ente

r60

0 A

cker

man

Rd

- E20

58P

O B

ox 1

8272

1C

olum

bus,

OH

432

18-2

721

U

SAcc

me.

osu.

edu

Pres

ort

Firs

t Cla

ssU

.S. P

osta

gePA

IDC

olum

bus,

OH

Perm

it N

o. 7

11

OH

IO S

TATE

’S D

IAB

ETE

S R

ES

EA

RC

H C

EN

TER

PR

ES

EN

TS

Glo

bal D

iabe

tes

Sum

mit

New

Hor

izon

s in

Dia

bete

s: G

enet

ics

to P

erso

naliz

ed H

ealth

Car

e

©20

12 T

he O

hio

Sta

te U

nive

rsity

Wex

ner

Med

ical

Cen

ter

CO

RP

2010

0320

-13

The

Seco

nd